Designing Scalable, Cost-Effective Manufacturing Platforms to Advance Phage Therapeutics Toward the Clinic
- Exploring how developers are advancing small-scale, high-throughput optimisation systems to streamline phage production and de-risk clinical manufacturing
- Understanding the critical parameters that define yield and quality – from oxygen and pH control to seeding and harvest timing – and how these influence capsid integrity, potency, and downstream formulation
- Examining how partnerships between academic platforms, SMEs, and contract manufacturers can enable early-stage innovators to generate robust data packages without the prohibitive costs of full GMP infrastructure